Skip to main contentSkip to navigation
Sirius Investors
Sage Therapeutics, Inc.

Sage Therapeutics, Inc.

SAGE
NASDAQHealthcare

Revenue Analysis - SAGE

Comprehensive quarterly and annual revenue breakdown by product lines and geographic regions to identify growth drivers and market opportunities.

SAGE Corporation

Annual

Revenue by Product Line

Latest quarterly revenue breakdown by product segments

Quarterly Product Revenue

Product Revenue Details

Detailed breakdown of revenue by product line

Collaboration Revenue Related Party

0.0% of total revenue

$23.2M

Other Revenue

0.0% of total revenue

$8.5M

Product

0.0% of total revenue

$0

Historical Revenue Data

Quarterly product revenue breakdown over time (Last 6 records)

Date
Collaboration Revenue Related Party
Other Collaboration Revenue
Other Revenue
Product
6/30/2025$23.2M$0$8.5M$0
3/31/2025$13.8M$0$236.0K$0
12/31/2024$17.6M$314.0K$0$2.1M
9/30/2024$11.0M$634.0K$0$843.0K
6/30/2024$7.4M$634.0K$0$600.0K
3/31/2024$6.2M$0$0$1.7M

Revenue Trend Analysis

Analysis of major growing and declining segments based on recent revenue data

Product Segments

Growing Segments
Other Revenue+3480.9%
Collaboration Revenue Related Party+67.9%

Earnings Reports

Want to see how SAGE's earnings relate to revenue? View quarterly earnings results, EPS history, and earnings surprises to understand the company's profitability.

View Earnings Reports